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This article is one of three in this issue (see also the articles
by Richards and by Edmond) adapted from a joint plenary
address entitled “Can We Really Get to Zero?” given at the
18th Annual Meeting of the Society for Healthcare Epide-
miology of America (Orlando, Florida; April 5–8, 2008). The
plenary session was structured as a formal debate, and each
speaker was assigned a point of view to represent. The po-
sitions presented may or may not represent the actual opin-
ions of the authors.—The Editor
Why would the 2008 Society for Healthcare Epidemiology
of America (SHEA) Annual Meeting planning committee
choose the topic “getting to zero”? As the open session
speaker, I can presume that they picked this topic because it
was timely, and of interest to many, but also controversial.
It is timely, because of the significant advances in infection
prevention over the past few years that have demonstrated
that many healthcare-acquired infections (HAIs) may be
preventable and that successfully implemented interventions
can significantly reduce HAI rates in diverse settings. Dra-
matic reductions in reported rates of catheter-related blood-
stream infection (BSI) and ventilator-associated pneumonia
in intensive care units (ICUs), through targeted efforts, have
inspired healthcare epidemiologists, infection prevention spe-
cialists, intensivists, patient safety professionals, hospitals, and
private, governmental, and community-based organizations
to set more aggressive goals and targets to reduce the risk of
HAIs.
“Elimination of HAIs,” “zero tolerance for HAIs,” “tar-
geting zero HAIs,” and other catch phrases became calls to
action, sound bites for marketing campaigns, and slogans to
martial enthusiasm for the cause. The passion and emotion
surrounding these specific choices of words have engendered
considerable controversy. “Zero tolerance” has been inter-
preted by some to be punitive or intolerant toward healthcare
workers and those people trying to prevent infections. I, per-
sonally, have never been a fan of the “zero tolerance” concept
in healthcare epidemiology or as an approach to dealing with
other complex public health challenges, such as underage
drinking, sexually transmitted infections, HIV transmission
risk, or tobacco and substance abuse. Perhaps this is because
I have been working in healthcare epidemiology and taking
care of patients for 20 years, or perhaps it is because I have
3 teenaged children. Although I am very passionate about
and committed to trying to reduce the risk of HAIs and
setting aggressive goals for the reduction of HAIs, I do not
think the zero tolerance approach helps as much as it hurts
our cause.
The concept of “targeting zero HAIs” is controversial, be-
cause many people believe it sets unrealistic or impossible
expectations that all HAIs are preventable and that any HAI
that may occur was due to an error or a broken process. To
me, “targeting zero” is problematic, because it does not ad-
dress the variation in the risk of HAIs in different patient
populations or settings, it does not address the denominator
or time frame that is necessary to understand rates of infec-
tion, and it inherently seems scientifically unrealistic. Al-
though I believe now that many more HAIs are preventable
than I thought even a few years ago, I do not believe our
science is yet robust enough to prevent all HAIs. When taken
as a “big, hairy, audacious goal,” trying to eliminate HAIs
seems quite laudable, however.
Some of the controversy has arisen because of the way
different people think about using marketing campaigns and
slogans to drive change or set agendas. It is actually very
difficult to prevent HAIs. Hospitals, healthcare workers, pa-
tients, and healthcare delivery are all complex and ever-
changing systems. Resources for healthcare epidemiology and
infection prevention research and operations are actually
quite limited, given the scope of the problem. It has taken
decades of research, operational improvements, multidisci-
plinary collaborations, and policy changes to realize the dra-
matic reductions in HAIs reported in the past several years.
To some, the slogans seem like unrealistic, unfunded man-
dates that demand perfect outcomes without providing the
resources, the infrastructure, or the science to do the work
or move the field forward. In some instances, it has been
perceived that the slogans have fueled the fire, by setting
expectations that all HAIs are preventable. Thus, patients and
the public might think that any HAI is the result of an error
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or suboptimal process; the Centers for Medicare and Medi-
caid Services (CMS) and insurers could refuse payment for
“never events.”
So, why was I asked to give this talk? I am the past president
of SHEA and a member of the Association of Professionals
in Infection Control and Epidemiology (APIC). I work at
Washington University and Barnes-Jewish Hospital, part of
the BJC HealthCare system. These institutions, along with my
infectious diseases and infection prevention specialist col-
leagues in the BJC Infection Control Consortium, have a long
track record of reducing the rate of HAIs and of doing re-
search studies on the risk factors, outcomes, and prevention
of HAIs, with funds from the Centers for Disease Control
and Prevention (CDC) Epicenters Program. I work at an
institution that targets “zero.” We still have HAIs, but we
never stop trying to prevent them. Philosophically, I prefer
to set aggressive targets, even though they may not be at-
tainable, rather than set the bar low enough to ensure success.
Last but not least, I am an incurable optimist, and I suspect
they asked me to speak to help motivate everyone to believe
in their ability to significantly reduce HAIs.
So, how did we get to the point that people are actually
talking about eliminating HAIs? Ten years ago, the very
thought was inconceivable, and now it’s front and center. The
history of modern healthcare epidemiology and infection pre-
vention is relatively short. Let me review some of the major
landmarks in the history of modern hospital infection pre-
vention. In the 1950s, hospital outbreaks of Staphylococcus
aureus infection were reported that raised awareness about
the risks of infection transmission in hospitalized patients. In
the 1970s, the CDC developed infection control expertise by
performing research and outbreak investigations, training a
cadre of physicians and nurses in healthcare epidemiology,
performing and supervising concurrent surveillance activities
in hospitals, and standardizing surveillance definitions for
HAIs. The Joint Commission prioritized systems and guide-
lines for infection prevention in hospitals to be used with
hospital accreditation procedures. The National Nosocomial
Infection Surveillance System began in 1970, with 62 hospitals
in 31 states. In 1972, APIC was established, and SHEA began
in 1981. The CDC and the Healthcare Infection Control Ad-
visory Committee developed the first major guidelines for
prevention of HAIs in the 1980s. In 1985, the Study on the
Efficacy of Nosocomial Infection Control reported specific
structures and processes linked to reduced infection rates. In
this landmark study, it was suggested that as many as 30%
of HAIs might be preventable.1,2
Healthcare delivery expanded rapidly over the next 2 de-
cades, with shorter lengths of hospital stay and increasingly
complicated surgical techniques, invasive procedures, and im-
munosuppressive therapy for cancer, transplants, rheuma-
tologic conditions, and other diseases. The severity of illness
and the age of inpatients increased, as did the prevalence of
immunosuppression, implants, hardware, and invasive de-
vices. Reported HAI rates remained relatively steady from
1975 through 1990, although we do not have an accurate
surveillance system to track actual HAI rates from all hospitals
in the United States.
In the 1990s, the Joint Commission increased regulation
of hospital infection control activities, and quality improve-
ment, quality assurance, and performance improvement pro-
grams expanded in hospitals. HAI rates reported to the Na-
tional Nosocomial Infection Surveillance System declined
throughout the decade, although there were significant in-
creases in the rates of infections caused by antimicrobial-
resistant organisms.3 Alcohol-based hand hygiene products
were introduced and became widely disseminated in hospitals
to reduce the rate of infections. The CDC Epicenters Program
began, in 1997, to fund research in the prevention and control
of HAIs. In 1998, the Institute of Medicine report “To Err is
Human” was published, and it ignited the patient safety
movement, by focusing renewed attention on preventing ad-
verse events and errors in health care.4 By 1999, the National
Nosocomial Infection Surveillance System had expanded to
285 hospitals in 42 states. The patient safety movement helped
infection prevention and healthcare epidemiology, by broad-
ening the approaches to include root cause analysis, failure
modes and effects analysis, and sentinel event analysis.
Since 2000, the rate of change and the challenges to health-
care epidemiology and infection prevention have moved at
the speed of light, compared with the prior 2 decades. The
Agency for Healthcare Research and Quality funded patient
safety research, and the National Nosocomial Infection Sur-
veillance System evolved into the National Healthcare Safety
Network, with an ever expanding number of participating
hospitals.5 There was enhanced public awareness of the im-
portance of HAIs; and the CMS, the Joint Commission, the
National Quality Foundation, the National Patient Safety
Foundation, the Institute for Health Care Improvement, com-
munity-based organizations, and patient advocacy groups all
became more active and collaborated to help prevent HAIs.
Hospital epidemiology and infection control made a notice-
able directional change from surveillance to interventions,
first at single centers and then in multicenter initiatives. Suc-
cessful interventions to reduce catheter-related BSI rates and
ventilator-associated pneumonia rates in ICUs were reported,
along with increasingly successful interventions using care
“bundles,” collaboratives, and regional initiatives.6-13 Public
reporting of HAIs increased, and the World Health Organi-
zation began the “Clean Care is Safer Care” Campaign to
reduce HAIs on a global scale. Infection control measures
became law in some states, along with laws requiring that
rates of methicillin-resistant S. aureus (MRSA) infection be
reported and that active surveillance for MRSA be performed.
Chlorhexidine body washing has been reported to reduce
infection rates in some settings,14 and some centers reported
dramatic reductions in the rate of MRSA infection with
“search and destroy” approaches, including active surveil-
lance, contact isolation, and decolonization therapy.11 The
CMS developed the value-based purchasing plan that is in-
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tended to reduce payments to hospitals for HAIs and “never
events.” The continued reports of success in reducing the rate
of HAIs, in some cases, to zero spurred interest in the “elim-
ination of HAIs,” “getting to zero,” and “zero tolerance”
slogans.
But what is zero? Although zero actually has several def-
initions, most of us think of zero as an arithmetical symbol
denoting the absence of all magnitude or quantity. Usually,
epidemiologists don’t deal well with zero, because it lacks a
denominator and a time frame for exposure risk. What about
trying to eradicate HAIs? The CDC defines eradication as a
permanent reduction to zero of the worldwide incidence of
infection caused by a specific agent. Eradication occurs with
deliberate efforts and creates an environment in which in-
tervention measures are no longer needed.
There are specific criteria for infectious disease eradication
initiatives: biologic feasibility (are humans the only reser-
voir?); the burden of disease, disability, and death; and the
availability of an effective practical intervention (eg, drugs or
vaccine). Ideally, interventions should be safe, inexpensive,
long-lasting, and easily deployed. One must also assess the
cost effectiveness of eradication, compared with the ongoing
control measures, and understand the operational and tech-
nical feasibility of implementing eradication strategies.
Last, but not least, there has to be a global capacity for the
political, financial, managerial, and technical support needed
for worldwide initiatives. These considerations were all ad-
dressed when diseases like smallpox, polio, measles, dracun-
culiasis, lymphatic filariasis, onchocerciasis, Chagas disease,
and Hansen disease were targeted for eradication. This model
doesn’t exactly work for HAIs, because we deal with many
different organisms and types of infections, humans are not
the only reservoir, many of the organisms are normal flora,
and relatively limited scientific and operational resources have
actually been dedicated to preventing HAIs. Elimination of
infectious disease is defined as the reduction to zero of the
incidence of infection in a defined geographic area. This re-
quires ongoing intervention measures, because the agent still
exists elsewhere and could be imported. This doesn’t exactly
fit HAIs, but it is an interesting model.
On the other hand, is the big, hairy, audacious goal a good
model?15 A big, hairy, audacious goal is a tangible, energizing,
and highly focused goal that requires little or no explanation.
It reaches out and grabs you in the gut. Ideally, a big, hairy,
audacious goal preserves a business’ core value and ideology,
but some people think that a consistent pattern of making
bold, risky investments in audacious projects stimulates for-
ward progress. So, I can understand trying to eliminate ven-
tilator-associated pneumonia, catheter-related BSI, and other
HAIs as big, hairy, audacious goals. Why? Because we have
been making progress in reducing the rate of HAIs. The Na-
tional Nosocomial Infection Surveillance System reported
that ventilator-associated pneumonia and BSI rates declined,
from 2001 to 2004, in multiple types of ICUs.3,5 The Pitts-
burgh Regional Health Initiative reported a 68% reduction
in catheter-related BSI rates, in 32 hospitals in southwestern
Pennsylvania, from 2001 through 2005.11 Johns Hopkins Hos-
pital reported dramatic reductions in rates of catheter-related
BSI from 2001 through 2005 (Pat Rosenbaum, personal com-
munication). Pronovost et al.12 reported significant reduc-
tions in catheter-related BSI rates in Michigan hospitals that
participated in the Keystone Center for Patient Safety Project.
The Institute for Health Care Improvement’s 100,000 Lives
Campaign reported significant decreases in rates of HAIs,
with several hospitals reporting reductions in rates of ven-
tilator-associated pneumonia and of catheter-related BSI to
zero.10,16 At BJC hospitals, aggressive, targeted interventions
reduced ventilator-associated pneumonia rates and catheter-
related BSI rates, dramatically, over the past 8 years.6,8,9,12
The important point is understanding how and why HAI
rates have been reduced. I think that, in hospitals that have
successfully reduced HAI rates, there has been an increased
focus on the specific mechanics of HAI prevention. There
has been a culture change in many institutions. HAI preven-
tion has become more multidisciplinary and team based;
there is more administrative support and accountability.
In many settings, principles of patient safety, quality im-
provement, performance improvement, lean production, and
Six Sigma have been incorporated into HAI prevention. Sur-
veillance and feedback measuring processes and outcomes
have gotten better and more timely. Enhanced reporting of
HAI rates and enhanced transparency of reporting have
helped focus attention on the problem, along with imple-
menting multiple, iterative interventions, including educa-
tion, evidenced-based policies and procedures, checklists,
standardized orders, competency assessments, and monitor-
ing tools. Marketing campaigns, visual aids, rewards, and in-
centives have also helped in our program. Additional mea-
sures suggested for fostering success in reducing HAIs include
critical event analysis of each infection, engaging leadership
and recruiting champions, daily assessment of devices, rapid
response teams, infection control liaisons, weekly executive
reports, focusing on systems reliability and simplification, and
persistence. Interestingly, multiple different, often bundled,
approaches have been used. Zell et al.16 suggest that it requires
strong will, application of evidence-based practices, and ro-
bust execution to get to zero.
It has been beneficial for healthcare workers to learn from
highly reliable organizations and to adopt applications from
other industries (from General Electric, Six Sigma; and from
Toyota, lean production). The Institute for Health Care Im-
provement has taught us a great deal about the science of
implementation and the value of “campaigns.” The rates of
HAIs have been reduced, because multidisciplinary groups
worked together and shared best practices and success stories
across hospitals and regions, so that they could be replicated,
and because the focus was personal—protecting patients and
saving lives.
There are a number of caveats, however. There have been
dramatic reductions in the rates of HAIs seen in many hos-
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pitals, yet actual reported data on national rates of HAIs are
limited. It is very hard to comprehensively measure actual
HAI rates and numbers and “lives saved.” Reductions in HAIs
don’t always correlate with reduced mortality. Most publicly
quoted national HAI numbers are based on limited 2002
data17 and older estimates created before the dramatic declines
in HAI rates. Recent reports of lowered HAI rates necessitate
more accurate measurements and not just estimates. Our
current HAI surveillance methods remain somewhat variable
and imperfect. Most of the reductions in HAIs are reported
in ICUs, but most HAIs occur outside the ICU, and we know
less about the epidemiology and prevention of non-ICU
HAIs.
There are still a number of challenges and limitations to
the existing infection control knowledge base. It is very dif-
ficult to do randomized, controlled trials of infection pre-
vention strategies. Infection prevention research and data are
often limited by lack of funding and suboptimal study designs
(eg, before-and-after studies without adequate controls, small
sample sizes, single-center studies, short-term follow-up, lim-
ited patient populations, and inability to control for comor-
bidities or to perform multivariable analysis). There are many
unanswered questions about the best ways to prevent infec-
tions, the cost-effectiveness of different interventions, and
which aspects of care “bundles” are the most important.
Whether better risk prediction models can be developed to
target prevention strategies to the patients at highest risk,
whether better risk stratification can be used to more effec-
tively predict which HAIs are preventable across populations
and centers, and whether reductions in mortality can be dem-
onstrated along with reduced HAI rates remain to be seen.
Given the current scientific evidence in the field, it is unlikely
that all HAIs are preventable. Currently, we can only guess
what proportion is actually preventable. Even in error-free
settings with perfect healthcare delivery and implementation
of best practices, HAIs can still occur. If we want to move
beyond this limitation, we need to advance the science in the
field.
Currently, the amount of federal and state resources ded-
icated to HAI prevention and research is not proportional to
the estimated public health burden of HAIs. If we want to
“eliminate HAIs,“ then we must work together to garner the
additional resources for research and infection control pro-
grams, so that we can more effectively try to “eliminate HAIs.”
Otherwise, as a good friend once told me, “a vision without
resources is just a hallucination.”
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